EDESA BIOTECH, INC. Proceeds from Divestiture of Interest in Subsidiaries and Affiliates
EDESA BIOTECH, INC. (EDSA) reported Proceeds from Divestiture of Interest in Subsidiaries and Affiliates of $1.00 thousand for the 6-month period ending 2019-03-31, per its 10-Q filed 2019-05-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates · last filed 2019-05-08
- 2019-03-31: Proceeds from Divestiture of Interest in Subsidiaries and Affiliates 6 month $1.00K.
- 2018-03-31: Proceeds from Divestiture of Interest in Subsidiaries and Affiliates 6 month $0.00.
| Period end | Proceeds from Divestiture of Interest in Subsidiaries and Affiliates 6 month |
|---|---|
| 2019-03-31 | $1.00K 10-Q · filed 2019-05-08 |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |